简介:
Overview
This protocol describes a gut microbiota antigen-specific T cell adoptive transfer colitis model. CD4 + T cells from CBir1 TCR transgenic mice are transferred into Rag1 -/- mice, inducing intestinal inflammation.
Key Study Components
Area of Science
- Neuroscience
- Immunology
- Gastroenterology
Background
- Inflammatory bowel disease (IBD) poses significant health challenges.
- This model aids in understanding IBD mechanisms.
- It evaluates potential treatments for IBD.
- Insights into T-cell responses to gut bacteria are provided.
Purpose of Study
- To develop a model for studying IBD.
- To explore T-cell responses to gut microbiota antigens.
- To assess therapeutic interventions for IBD.
Methods Used
- Isolation of CD4 + T cells from transgenic mice.
- Adoptive transfer of T cells into recipient mice.
- Induction of intestinal inflammation.
- Surgical procedures for tissue analysis.
Main Results
- Successful induction of colitis in recipient mice.
- Characterization of T-cell responses to microbiota antigens.
- Insights into the role of gut bacteria in IBD.
- Potential for evaluating therapeutic strategies.
Conclusions
- The model provides a platform for IBD research.
- It enhances understanding of immune responses to gut antigens.
- Future studies can leverage this model for treatment evaluation.
What is the significance of this colitis model?
This model helps in understanding the mechanisms of IBD and evaluating treatments.
How are T cells isolated for this study?
CD4 + T cells are isolated from CBir1 TCR transgenic mice.
What is the role of Rag1 -/- mice in this protocol?
Rag1 -/- mice serve as recipients for the T cell transfer, leading to colitis.
What insights does this study provide?
It provides insights into how gut bacteria antigens induce T-cell responses.
What are the next steps after inducing colitis?
After euthanizing the mouse, surgical procedures are performed for tissue analysis.
How does this model contribute to IBD research?
It offers a platform for studying immune responses and testing therapies.